Theratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the recipient of a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 38,400 shares, a drop of 53.5% from the December 31st total of 82,500 shares. Based on an average daily trading volume, of 93,600 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.2% of the company's shares are sold short.
Theratechnologies Stock Performance
Shares of Theratechnologies stock traded up $0.02 during midday trading on Monday, reaching $1.46. 81,644 shares of the company's stock traded hands, compared to its average volume of 107,858. The company has a market cap of $67.13 million, a PE ratio of -14.60 and a beta of 1.30. The stock has a 50 day moving average of $1.64 and a 200-day moving average of $1.41. Theratechnologies has a 12 month low of $1.08 and a 12 month high of $2.18.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Theratechnologies stock. National Bank of Canada FI raised its position in shares of Theratechnologies Inc. (NASDAQ:THTX - Free Report) by 29.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 186,815 shares of the company's stock after buying an additional 42,435 shares during the quarter. National Bank of Canada FI owned about 0.41% of Theratechnologies worth $232,000 at the end of the most recent quarter.
About Theratechnologies
(
Get Free Report)
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Recommended Stories
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
